[Tactics of cytostatic therapy of primary and secondary (post-erythremic) myelofibrosis].
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001389:Azirines / Q000627:therapeutic use; D002066:Busulfan / Q000627:therapeutic use; D005260:Female; D006801:Humans; D004915:Leukemia, Erythroblastic, Acute / Q000150:complications; D008297:Male; D008875:Middle Aged; D008927:Mitobronitol / Q000627:therapeutic use; D009943:Organophosphorus Compounds / Q000627:therapeutic use; D055728:Primary Myelofibrosis / Q000188:drug therapy* / Q000209:etiology / Q000532:radiotherapy
D000970:Antineoplastic Agents; D001389:Azirines; D009943:Organophosphorus Compounds; D008927:Mitobronitol; D002066:Busulfan
O taktike tsitostaticheskoĭ terapii u bol'nykh s pervichnym i vtorichnym (posteritremicheskim) mielofibrozom